• OPEN AN ACCOUNT
Indian Indices
Nifty
25,405.30 -48.10
(-0.19%)
Sensex
83,239.47 -170.22
( -0.20%)
Bank Nifty
56,791.95 -207.25
( -0.36%)
Nifty IT
38,854.30 -24.80
( -0.06%)
Global Indices
Nasdaq
44,498.76 -17.19
(-0.04%)
Dow Jones
6,247.07 28.06
(0.45%)
Hang Seng
39,705.85 -56.63
(-0.14%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.59 -0.04
(-0.04%)
EUR-INR
100.92 0.38
(0.38%)
GBP-INR
117.62 0.20
(0.17%)
JPY-INR
0.60 0.00
(0.46%)

EQUITY - MARKET SCREENER

Relaxo Footwears Ltd
Industry :  Leather / Leather Products
BSE Code
ISIN Demat
Book Value()
530517
INE131B01039
84.2807815
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RELAXO
64.29
10947.07
EPS(TTM)
Face Value()
Div & Yield %
6.84
1
0
 

cress&a railway solutions ltd
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
Jul 03,2025
Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals has acquired Utility Therapeutics for a consideration of $12 million in staggered manner over period of time, depending on milestones achieved.

Utility Therapeutics is involved in the development and approval of two brand pharmaceutical products for the treatment of urinary tract infections (UTI).

-“Pivya” is an FDA approved product to treat uncomplicated UTIs in the US market.

-“MEC” is a product in development for treatment of the complicated UTIs in the US market.

As a product development company they have minimal turnover in last 3 years.